When planning a technology transfer, choosing a CDMO partner with deep scientific, operational, and cross‑functional expertise can make all the difference. In this expert panel discussion, Rentschler Biopharma’s experts share real‑world lessons from supporting complex programs through phase‑appropriate development, scale‑up, and cGMP manufacturing. They offer a transparent look at what truly drives a smooth, efficient, and reliable tech‑transfer experience.

Join:

• Dante Lepore, Ph.D. — Laboratory Head, Downstream Process Development
• Jessica Feldman, Ph.D. — Senior Director, Process Development
• Patrick Cushing, Ph.D. — Vice President, Operations
• Robin Lynge — Senior Director, Business Development

Key Insights:

• Essential elements of a successful tech transfer

Core scientific and operational considerations as processes advance to cGMP production.

• What to evaluate before initiating a transfer